From trademarks, packaging and label designs to risk assessment, Med-ERRS® is uniquely suited to assist global pharmaceutical, biotechnology, and healthcare technology companies in evaluating the safety of their products.
Med-ERRS was established in 1997 in response to a growing need within the pharmaceutical industry to develop trademarks, packaging and labels that minimize the potential for medication errors. Since then, we have worked with over 200 pharmaceutical companies to provide services that have helped our clients make medication safety-focused decisions regarding their products.
A wholly owned, for-profit subsidiary of the nonprofit Institute for Safe Medication Practices (ISMP), Med-ERRS was founded on a heritage of expertise in medication safety. Our relationship with our parent company gives us an industry advantage, enabling us to apply their breadth and depth of medication safety knowledge, along with our medication safety experience, to the services we provide to our clients.
The Med-ERRS staff consists of healthcare professionals with extensive experience in clinical practice. We understand the real-life situations that occur when products are used in the healthcare environment. More than that, we integrate our knowledge and experience with the input of practicing clinicians in the field. This allows us to systematically analyze potential trademarks, package labels, and technology to provide clients with an understanding of their products’ risks related to medication safety.
There are many applications for our services. Depending on the stage of a product’s development, our capabilities have benefited clients in areas including:
- Intellectual property and trademark development
- Trademark law
- Product management
- Regulatory affairs
- Drug safety
- Market research